StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
5
Publishing Date
2023 - 11 - 01
4
2023 - 10 - 16
3
2023 - 10 - 04
9
2023 - 09 - 20
3
2023 - 09 - 19
4
2023 - 09 - 18
4
2023 - 07 - 13
3
2023 - 05 - 05
3
2023 - 03 - 30
3
2023 - 03 - 29
3
2023 - 01 - 09
3
2023 - 01 - 03
3
2022 - 10 - 26
5
2022 - 10 - 12
4
2022 - 05 - 26
3
2022 - 05 - 20
3
2022 - 05 - 12
3
2022 - 03 - 16
3
2022 - 03 - 01
3
2022 - 02 - 24
3
2022 - 01 - 18
2
2022 - 01 - 06
2
2021 - 12 - 01
3
2021 - 11 - 30
2
2021 - 11 - 15
2
2021 - 10 - 11
2
2021 - 10 - 08
2
2021 - 10 - 07
11
2021 - 10 - 06
3
2021 - 10 - 04
2
2021 - 10 - 01
2
2021 - 09 - 30
12
2021 - 09 - 21
3
2021 - 09 - 20
2
2021 - 09 - 15
3
2021 - 09 - 13
3
2021 - 09 - 08
2
2021 - 08 - 26
2
2021 - 08 - 24
2
2021 - 08 - 11
3
2021 - 08 - 10
3
2021 - 07 - 27
2
2021 - 07 - 23
2
2021 - 07 - 09
2
2021 - 05 - 28
2
2021 - 05 - 24
2
2021 - 05 - 07
2
2021 - 05 - 06
2
2021 - 04 - 27
2
2021 - 04 - 23
2
2021 - 04 - 01
2
2021 - 03 - 25
2
2021 - 03 - 15
2
2021 - 03 - 09
2
2021 - 03 - 08
2
2021 - 03 - 01
2
2021 - 02 - 17
2
2021 - 01 - 19
3
2020 - 12 - 21
2
2020 - 12 - 15
2
Sector
Distribution services
1
Finance
1
Health technology
5
N/a
1
Technology services
1
Tags
Acquisition
3
Agreement
11
America
5
Application
4
Approval
3
Battery
3
Biotech-bay
3
Biotech-beach
5
Cancer
8
Care
3
Ceo
5
Clinical-trials-phase-ii
3
Conference
45
Contract
4
Corporation
12
Distribution
5
Earnings
6
Energy
10
Europe
4
Financial
81
Genetown
4
Global
16
Group
15
Growth
14
Health
11
Innovation
4
International
4
Management
8
Market
28
Meeting
8
Molecular
5
N/a
459
Nasdaq
4
Offering
10
Pharma
5
Pharmaceutical
5
Pharmaceuticals
9
Phase 1
8
Phase 2b
5
Positive
4
Preclinical
5
Presentation
6
Program
7
Report
38
Research
6
Results
126
Sales
4
Sciences
4
Sclerosis
4
Services
6
Solutions
5
Study
16
Symposium
6
System
8
Technology
8
Therapeutics
29
Treatment
9
Trial
13
Update
18
Year
8
Entities
4d molecular therapeutics inc
1
Bionano genomics, inc.
1
Black diamond therapeutics, inc.
1
Creatd inc.
1
Ecmoho limited
1
Evofem biosciences, inc.
1
Merus n.v.
1
Molecular data inc.
1
Nasdaq, inc.
1
Symbols
BDTX
1
BNGO
1
CRTD
1
EVFM
1
FDMT
1
MKD
1
MKDTY
1
MOHO
1
MRUS
1
NDAQ
1
Exchanges
Nasdaq
5
Crawled Date
2022 - 10 - 26
5
Crawled Time
09:00
1
12:20
2
21:00
2
Source
www.globenewswire.com
5
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2022 - 10 - 26
tags :
Molecular
save search
4D Molecular Therapeutics Interim Clinical Data from the On-going Phase 1/2 Clinical Trial of 4D-710 for Cystic Fibrosis Lung Disease to be Presented at NACFC 2022
Published:
2022-10-26
(Crawled : 21:00)
- globenewswire.com
FDMT
M
|
$24.25
-2.26%
-2.29%
290K
|
Health Technology
|
214.94%
|
O:
1.17%
H:
34.79%
C:
14.63%
fibrosis
lung
disease
trial
therapeutics
molecular
cystic fibrosis
Delisting of Securities of Evofem Biosciences, Inc.; Creatd Inc.; Molecular Data Inc.; ECMOHO Limited; and ALFI, Inc. from The Nasdaq Stock Market
Published:
2022-10-26
(Crawled : 21:00)
- globenewswire.com
NDAQ
|
$61.5
0.67%
0.68%
2.3M
|
Finance
|
2.45%
|
O:
0.6%
H:
1.76%
C:
0.43%
CRTD
|
$1.82
0.55%
122.27%
3.4K
|
Technology Services
|
226.5%
|
O:
-5.79%
H:
4.34%
C:
-6.55%
molecular
market
Black Diamond Therapeutics Presents Preclinical Data on BDTX-1535 and BDTX-4933 at the 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Published:
2022-10-26
(Crawled : 12:20)
- globenewswire.com
BDTX
|
$5.06
1.0%
0.79%
360K
|
Health Technology
|
204.82%
|
O:
0.6%
H:
11.98%
C:
4.19%
bdtx-1535
preclinical
symposium
therapeutics
molecular
cancer
Hamilton and Bionano Genomics Announce Commercial Availability of World’s First Ultra High Molecular Weight DNA Extraction Automation Solution for OGM
Published:
2022-10-26
(Crawled : 12:20)
- globenewswire.com
BNGO
|
$0.7611
-4.19%
-3.78%
790K
|
Health Technology
|
-67.52%
|
O:
1.28%
H:
16.03%
C:
7.17%
dna
commercial
genomics
molecular
Merus Presents First in Human Data on MCLA-129 at the 34th EORTC/NCI/AACR (ENA) Symposium on Molecular Targets and Cancer Therapeutics
Published:
2022-10-26
(Crawled : 09:00)
- globenewswire.com
MRUS
|
$41.97
2.82%
2.72%
740K
|
Health Technology
|
77.39%
|
O:
-1.06%
H:
3.59%
C:
-8.84%
mcla-129
symposium
therapeutics
molecular
cancer
Gainers vs Losers
61%
39%
Top 10 Gainers
CSSE
4
|
$0.4253
179.25%
64.77%
210M
|
Consumer Services
BOF
|
$2.08
77.78%
41.21%
110M
|
ILAG
|
$0.54
12.27%
40.62%
3.7M
|
LICN
|
$0.999
78.39%
40.49%
15M
|
AMST
|
$3.4
70.0%
39.58%
70M
|
Technology Services
MTC
|
$3.6
60.71%
38.04%
9.1M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.458
14.5%
30.92%
91K
|
Health Services
WHLM
|
$6.25
35.87%
28.46%
700K
|
Commercial Services
MULN
|
News
|
$3.77
38.1%
27.78%
13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.